Cargando…

Effect of early GnRH antagonist administration on assisted reproductive technique outcomes in normal responders

One of the main questions in assisted reproductive techniques is how to prevent premature LH surge using a variety of protocols depending on either pituitary down-regulation, in GnRH agonist protocols, or by receptors blockage, in GnRH protocols. It is possible to say that GnRH protocols are most po...

Descripción completa

Detalles Bibliográficos
Autor principal: Al-Obaidi, Manal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Carol Davila University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999099/
https://www.ncbi.nlm.nih.gov/pubmed/35419110
http://dx.doi.org/10.25122/jml-2021-0286
_version_ 1784685109777006592
author Al-Obaidi, Manal
author_facet Al-Obaidi, Manal
author_sort Al-Obaidi, Manal
collection PubMed
description One of the main questions in assisted reproductive techniques is how to prevent premature LH surge using a variety of protocols depending on either pituitary down-regulation, in GnRH agonist protocols, or by receptors blockage, in GnRH protocols. It is possible to say that GnRH protocols are most popular nowadays. The study aimed to assess the effectiveness of early antagonist administration during days ≤6 and later antagonist administration on days >6 on assisted reproductive outcomes. Women admitted to the ART Department at the High Institute for Infertility Diagnosis and ART, Al-Nahrain University, Baghdad, Iraq were included in the study. Reproductive outcomes were evaluated in early ≤6 and late >6 antagonist administration in a total of 44 normal responders, as follows. Sandwich protocols in 14 patients that received antagonists in the first 3 days of the follicular phase and conventional flexible antagonist protocol in 30 patients. We compared the outcomes between the two groups. There were no differences between early antagonist administration ≤6 and late >6 days in the number of MII oocytes, 2PN, the number of transferred embryos, grades of the embryos, and pregnancy rates. However, there were statistically significant differences between the duration of stimulation and the total Gonadotropin dose required. There was no effect of antagonist administration on days ≤6 and >6 on controlled ovarian stimulation on assisted reproductive outcomes.
format Online
Article
Text
id pubmed-8999099
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Carol Davila University Press
record_format MEDLINE/PubMed
spelling pubmed-89990992022-04-12 Effect of early GnRH antagonist administration on assisted reproductive technique outcomes in normal responders Al-Obaidi, Manal J Med Life Original Article One of the main questions in assisted reproductive techniques is how to prevent premature LH surge using a variety of protocols depending on either pituitary down-regulation, in GnRH agonist protocols, or by receptors blockage, in GnRH protocols. It is possible to say that GnRH protocols are most popular nowadays. The study aimed to assess the effectiveness of early antagonist administration during days ≤6 and later antagonist administration on days >6 on assisted reproductive outcomes. Women admitted to the ART Department at the High Institute for Infertility Diagnosis and ART, Al-Nahrain University, Baghdad, Iraq were included in the study. Reproductive outcomes were evaluated in early ≤6 and late >6 antagonist administration in a total of 44 normal responders, as follows. Sandwich protocols in 14 patients that received antagonists in the first 3 days of the follicular phase and conventional flexible antagonist protocol in 30 patients. We compared the outcomes between the two groups. There were no differences between early antagonist administration ≤6 and late >6 days in the number of MII oocytes, 2PN, the number of transferred embryos, grades of the embryos, and pregnancy rates. However, there were statistically significant differences between the duration of stimulation and the total Gonadotropin dose required. There was no effect of antagonist administration on days ≤6 and >6 on controlled ovarian stimulation on assisted reproductive outcomes. Carol Davila University Press 2022-02 /pmc/articles/PMC8999099/ /pubmed/35419110 http://dx.doi.org/10.25122/jml-2021-0286 Text en ©2022 JOURNAL of MEDICINE and LIFE https://creativecommons.org/licenses/by/3.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Original Article
Al-Obaidi, Manal
Effect of early GnRH antagonist administration on assisted reproductive technique outcomes in normal responders
title Effect of early GnRH antagonist administration on assisted reproductive technique outcomes in normal responders
title_full Effect of early GnRH antagonist administration on assisted reproductive technique outcomes in normal responders
title_fullStr Effect of early GnRH antagonist administration on assisted reproductive technique outcomes in normal responders
title_full_unstemmed Effect of early GnRH antagonist administration on assisted reproductive technique outcomes in normal responders
title_short Effect of early GnRH antagonist administration on assisted reproductive technique outcomes in normal responders
title_sort effect of early gnrh antagonist administration on assisted reproductive technique outcomes in normal responders
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999099/
https://www.ncbi.nlm.nih.gov/pubmed/35419110
http://dx.doi.org/10.25122/jml-2021-0286
work_keys_str_mv AT alobaidimanal effectofearlygnrhantagonistadministrationonassistedreproductivetechniqueoutcomesinnormalresponders